Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Viracta Therapeutics
VIRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.211100
-0.01
-5.67%
Last update: 9:27 AM
15 minutes delayed
Get Report
Comment
Viracta Therapeutics (VIRX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Viracta Therapeutics (NASDAQ:VIRX) Stock
Viracta Therapeutics Stock (NASDAQ: VIRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, August 16, 2024
Viracta Therapeutics shares are trading lower...
Benzinga Newsdesk
Leerink Partners Downgrades Viracta Therapeut...
Benzinga Newsdesk
Thursday, August 15, 2024
RBC Capital Maintains Outperform on Viracta T...
Benzinga Newsdesk
Wednesday, August 14, 2024
Viracta Therapeutics shares are trading highe...
Benzinga Newsdesk
Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday?
Vandana Singh
Viracta Therapeutics Q2 2024 GAAP EPS $(0.25)...
Benzinga Newsdesk
Viracta Therapeutics Reported Phase 2 NAVAL-1...
Benzinga Newsdesk
Friday, August 09, 2024
Viracta Therapeutics Has Received A Notice Of...
Benzinga Newsdesk
Thursday, August 08, 2024
Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, July 29, 2024
On July 22, 2024, Viracta Therapeutics, Annou...
Benzinga Newsdesk
Tuesday, June 18, 2024
Viracta Therapeutics Granted US Patent #12012...
Benzinga Newsdesk
Tuesday, June 11, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Thursday, May 23, 2024
Oppenheimer Maintains Outperform on Viracta T...
Benzinga Newsdesk
Tuesday, May 14, 2024
Viracta Therapeutics Appoints Michael Faerm A...
Benzinga Newsdesk
Thursday, May 09, 2024
Viracta Therapeutics Q1 2024 Adj EPS $(0.23) ...
Benzinga Newsdesk
Wednesday, April 24, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, April 17, 2024
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Oppenheimer Maintains Outperform on Viracta T...
Benzinga Newsdesk
Tuesday, April 16, 2024
HC Wainwright & Co. Reiterates Buy on Viracta...
Benzinga Newsdesk
Monday, April 15, 2024
Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?
Vandana Singh
Viracta Therapeutics shares are trading lower...
Benzinga Newsdesk
Viracta Therapeutics Announces Topline Nana-v...
Benzinga Newsdesk
Monday, April 01, 2024
Viracta Therapeutics To Present Topline Nana-...
Benzinga Newsdesk
Tuesday, March 12, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Viracta...
Benzinga Newsdesk
Friday, March 08, 2024
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, February 29, 2024
Viracta Therapeutics Completes Second-Stage E...
Benzinga Newsdesk
Friday, January 05, 2024
CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Viracta ...
Benzinga Newsdesk
Thursday, January 04, 2024
Viracta Therapeutics Provides Clinical Update...
Benzinga Newsdesk
Tuesday, December 12, 2023
Viracta Therapeutics Says FDA Granted Orphan ...
Benzinga Newsdesk
Monday, December 04, 2023
Viracta Therapeutics Announces Interim Data F...
Benzinga Newsdesk
Friday, November 10, 2023
RBC Capital Maintains Outperform on Viracta T...
Benzinga Newsdesk
Thursday, November 09, 2023
Viracta Therapeutics shares are trading lower...
Benzinga Newsdesk
Viracta Therapeutics: Q3 Earnings Insights
Benzinga Insights
Viracta Therapeutics Q3 EPS $(0.33) Misses $(...
Benzinga Newsdesk
Wednesday, November 08, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Thursday, October 05, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
RBC Capital Reiterates Outperform on Viracta ...
Benzinga Newsdesk
Tuesday, August 15, 2023
Expert Ratings for Viracta Therapeutics
Benzinga Insights
RBC Capital Reiterates Outperform on Viracta ...
Benzinga Newsdesk
SVB Securities Maintains Outperform on Viract...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Viracta...
Benzinga Newsdesk
Monday, August 14, 2023
Viracta Therapeutics Q2 EPS $(0.32) Misses $(0.28) Estimate
Happy Mohamed
Tuesday, August 08, 2023
Viracta Therapeutics Announces Publication In Blood Advances Demonstrating Promising And Durable Signal Of Nana-val Efficacy In Patients With Relapsed Or Refractory Epstein-Barr Virus-Positive Lymphoma
Happy Mohamed
Monday, July 31, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
